Lack of the involvement of μ1-opioid receptor subtype on motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and-2 in the mouse

被引:11
|
作者
Narita, M
Ozaki, S
Ioka, M
Mizoguchi, H
Nagase, H
Tseng, LF
Suzuki, T
机构
[1] Hoshi Univ, Sch Pharm, Dept Toxicol, Shinagawa Ku, Tokyo 1428501, Japan
[2] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA
[3] Toray Ind Inc, Pharmaceut Res Lab, Dept Med Chem, Kanagawa 2488555, Japan
关键词
endomorphin-1; endomorphin-2; motivational effect; mu-opioid receptor subtypes; CXBK mice; lower midbrain;
D O I
10.1016/S0304-3940(01)01975-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study was designed to investigate the role of mu -opioid receptor subtypes in the motivational effect of endogenous mu -opioid receptor ligands, endomorphin-1 and -2. In C57BL/6J mice, endomorphin-1 produced a significant place preference, whereas endomorphin-2 exhibited a significant place aversion. These effects were abolished by a mu (1)/mu (2)-opioid receptor antagonist beta -funaltrexamine. Under these conditions, both endomorphin-1 and -2 produced their motivational effects in mu (1)-opioid receptor-deficient CXBK mice, indicating the mu (2)-opioid receptor involvement. Furthermore, in the lower midbrain including ventral tegmental area, both endomorphin-1 and -2 equally produced dose-related increases in guanosine-5'-o-(3-[S-35] thio) triphosphate bindings in C57BL/6J and CXBK mice. These findings indicate that endomorphin-1 and -2 may produce distinct motivational effects via respective mu (2)-opioid receptor isoforms in the mouse. Furthermore, endomorphin-1 and -2 produced the yl-resistant G-protein activation in the mouse lower midbrain. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [31] Repeated δ1-opioid receptor stimulation reduces δ2-opioid receptor responses in the SA node
    Deo, S. H.
    Johnson-Davis, S.
    Barlow, M. A.
    Yoshishige, D.
    Caffrey, J. L.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (05): : H2246 - H2254
  • [32] The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor
    LaVigne, Justin
    Keresztes, Attila
    Chiem, Daniel
    Streicher, John M.
    PHARMACOLOGICAL REPORTS, 2020, 72 (02) : 465 - 471
  • [33] Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1
    Jinsmaa, Yunden
    Marczak, Ewa
    Fujita, Yoshio
    Shiotani, Kirnitaka
    Miyazaki, Anna
    Li, Tingyou
    Tsuda, Yuko
    Arnbo, Akihiro
    Sasaki, Yusuke
    Bryant, Sharon D.
    Okada, Yoshio
    Lazarus, Lawrence H.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 84 (02) : 252 - 258
  • [34] Endogenous opioid peptides, endomorphin-1 and -2 and deltorphin I, stimulate angiogenesis in the CAM assay
    Dai, Xu
    Cui, Shi-gang
    Wang, Ting
    Liu, Qian
    Song, Hong-Jin
    Wang, Rui
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) : 269 - 275
  • [35] Effects of endomorphins-1 and-2, endogenous μ-opioid receptor agonists, on spontaneous alternation performance in mice
    Ukai, M
    Watanabe, Y
    Kameyama, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 395 (03) : 211 - 215
  • [36] Cardioprotective Effect of Selective μ2-Opioid Receptor Agonist Endomorphin-1 in Cardiac Reperfusion In Vivo and In Vitro
    Gorbunov, A. S.
    Mukhomedzyanov, A. V.
    Popov, S. V.
    Azev, V. N.
    Maslov, L. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, : 86 - 90
  • [37] Involvement of the endogenous opioid peptide on the antinociception induced by endomorphin-2 in the mouse spinal site
    Watanabe, H
    Sakurada, W
    Mizoguchi, H
    Watanabe, C
    Fujimura, T
    Sakurada, T
    Sakurada, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 71P - 71P
  • [38] Endomorphin-1 and endomorphin-2 show differences in their activation of μ opioid receptor-regulated G proteins in supraspinal antinociception in mice
    Sánchez-Blázquez, P
    Rodríguez-Díaz, M
    DeAntonio, I
    Garzón, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 291 (01): : 12 - 18
  • [39] Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat
    Champion, HC
    Zadina, JE
    Kastin, AJ
    Hackler, L
    Ge, LJ
    Kadowitz, PJ
    PEPTIDES, 1997, 18 (09) : 1393 - 1397
  • [40] Cross-tolerance between the different μ-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat
    Labuz, D
    Przewlocki, R
    Przewlocka, B
    NEUROSCIENCE LETTERS, 2002, 334 (02) : 127 - 130